Article Information
- Received May 3, 2021
- Revision received August 19, 2021
- Accepted August 22, 2021
- Published online September 13, 2021.
Author Information
- Kaja Nurm1,
- Mari Sepp1,
- Carla Castany-Pladevall3,4,5,
- Jordi Creus-Muncunill3,4,5,
- Jürgen Tuvikene1,2,
- Alex Sirp1,
- Hanna Vihma1,
- Derek J. Blake6,
- Esther Perez-Navarro3,4,5 and
- Tõnis Timmusk1,2
- 1Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn 12618, Estonia
- 2Protobios LLC, Tallinn 12618, Estonia
- 3Departament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Institut de Neurociències, Universitat de Barcelona, Barcelona, Catalonia 08036, Spain
- 4Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia 08036, Spain
- 5Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, 28031, Spain
- 6Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff CF24 4HQ, United Kingdom
- Correspondence should be addressed to Tõnis Timmusk at tonis.timmusk{at}taltech.ee.
Author contributions
Author contributions: K.N., M.S., J.T., and T.T. designed research; K.N., M.S., C.C.-P., J.C.-M., A.S., and H.V. performed research; K.N., M.S., C.C.-P., J.C.-M., J.T., A.S., H.V., D.J.B., E.P.-N., and T.T. analyzed data; K.N., M.S., J.T., D.J.B., E.P.-N., and T.T. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by the Estonian Research Council Institutional Research Funding IUT19-18 and Grant PRG805, the European Union through the European Regional Development Fund Project No. 2014-2020.4.01.15-0012, H2020-MSCA-RISE-2016 (Grant EU734791), and the Spanish government through the Spanish Ministry of Science, Innovation and Universities Grant PID2019-106447RB-100 (to E.P.-N.). D.J.B. was supported by the Medical Research Council (MRC) Grant MR/L010305/1. This work has also been partially supported by “TUT Institutional Development Program for 2016–2022” Graduate School in clinical medicine receiving funding from the European Regional Development Fund under Program ASTRA 2014-2020.4.01.16-0032 in Estonia.
Funding
Eesti Teadusagentuur (Estonian Research Council)
IUT19-18; PRG805European Union through the European Regional Development Fund
2014-2020.4.01.15-0012H2020-MSCA-RISE-2016
EU734791European Regional Development Fund
ASTRA 2014-2020.4.01.16-0032Spanish Ministry of Science, Innovation and Universities
PID2019-106447RB-100Medical Research Council, UK
MR/L010305/1
Other Version
- You are viewing the most recent version of this article.
- previous version (September 13, 2021).
Online Impact